Current Environment: Production

American Board of Pediatrics (General) | Education

Undergraduate School

Smith College

1985, Northhampton, MA

Medical School

New York University School of Medicine

1991, New York, NY

American Board of Pediatrics (General) | Publications

  1. Clinical Characteristics and Treatment of Histiocytic Disorders in Children. Hematol Oncol Clin North Am. 2025 Jun; 39(3):513-529. View Clinical Characteristics and Treatment of Histiocytic Disorders in Children. Abstract

  2. Histiocytic Disorders in Pediatric and Adult Patients. Hematol Oncol Clin North Am. 2025 Jun; 39(3):xi-xii. View Histiocytic Disorders in Pediatric and Adult Patients. Abstract

  3. Over 4 decades, French children teach about LCH. Blood. 2025 Mar 06; 145(10):1000-1001. View Over 4 decades, French children teach about LCH. Abstract

  4. Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia. Clin Cancer Res. 2024 Oct 01; 30(19):4388-4396. View Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia. Abstract

  5. Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and Diagnosis. Mod Pathol. 2024 Jul; 37(7):100509. View Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and Diagnosis. Abstract

  6. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia. JAMA Netw Open. 2024 05 01; 7(5):e2411726. View Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia. Abstract

  7. Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Cancer. 2024 Jul 15; 130(14):2416-2439. View Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Abstract

  8. Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib. Br J Dermatol. 2024 01 23; 190(2):283-284. View Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib. Abstract

  9. Acute infusion-related reactions in pediatric patients receiving etoposide at a tertiary cancer center. J Oncol Pharm Pract. 2024 Jan; 30(1):197-200. View Acute infusion-related reactions in pediatric patients receiving etoposide at a tertiary cancer center. Abstract

  10. Dr. Degar et al reply. J Rheumatol. 2023 07; 50(7):968-969. View Dr. Degar et al reply. Abstract

  11. Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure. Front Oncol. 2022; 12:1016318. View Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure. Abstract

  12. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging 18 F-FDG PET/CT: A retrospective study. Pediatr Blood Cancer. 2023 01; 70(1):e30057. View The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging 18 F-FDG PET/CT: A retrospective study. Abstract

  13. An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. J Rheumatol. 2022 Sep; 49(9):1042-1051. View An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. Abstract

  14. HLH treatment: smarter, not harder. Blood. 2022 06 16; 139(24):3453-3455. View HLH treatment: smarter, not harder. Abstract

  15. Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. Blood Adv. 2022 05 10; 6(9):2893-2896. View Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. Abstract

  16. Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. N Engl J Med. 2020 05 07; 382(19):1811-1822. View Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. Abstract

  17. Pediatric leukemia cutis: A case series. Pediatr Dermatol. 2019 Sep; 36(5):658-663. View Pediatric leukemia cutis: A case series. Abstract

  18. Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. J Clin Oncol. 2019 08 10; 37(23):2072-2081. View Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial. Abstract

  19. Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. Neurol Neuroimmunol Neuroinflamm. 2019 05; 6(3):e560. View Pediatric CNS-isolated hemophagocytic lymphohistiocytosis. Abstract

  20. A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia. J Immunother Cancer. 2019 03 20; 7(1):81. View A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia. Abstract

  21. Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. Blood Adv. 2019 02 26; 3(4):503-507. View Central nervous system-restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation. Abstract

  22. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J. 2019 Feb 14; 17(1):7. View Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Abstract

  23. Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. J Neuropathol Exp Neurol. 2018 12 01; 77(12):1079-1084. View Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. Abstract

  24. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Pediatr Blood Cancer. 2016 10; 63(10):1844-7. View Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency. Abstract

  25. Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck. AJNR Am J Neuroradiol. 2016 May; 37(5):910-6. View Imaging Features of Juvenile Xanthogranuloma of the Pediatric Head and Neck. Abstract

  26. Familial Hemophagocytic Lymphohistiocytosis. Hematol Oncol Clin North Am. 2015 Oct; 29(5):903-13. View Familial Hemophagocytic Lymphohistiocytosis. Abstract

  27. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2015 Dec; 62(12):2162-6. View Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study. Abstract

  28. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2015 Jun; 62(6):982-7. View Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Abstract

  29. Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. Pediatr Transplant. 2015 Mar; 19(2):E41-6. View Bone marrow engraftment and associated dermatologic sequelae in a three-yr-old after liver transplantation. Abstract

  30. Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. Br J Haematol. 2015 Jan; 168(1):94-101. View Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy. Abstract

  31. Medication errors in the home: a multisite study of children with cancer. Pediatrics. 2013 May; 131(5):e1405-14. View Medication errors in the home: a multisite study of children with cancer. Abstract

  32. BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate. AJP Rep. 2013 Oct; 3(2):63-6. View BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate. Abstract

  33. Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. J Clin Oncol. 2012 Oct 10; 30(29):3625-32. View Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia. Abstract

  34. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012 Jan; 156(2):163-72. View Recent advances in the understanding of Langerhans cell histiocytosis. Abstract

  35. Neonatal enteroviral sepsis/meningoencephalitis and hemophagocytic lymphohistiocytosis: diagnostic challenges. Am J Perinatol. 2011 May; 28(5):337-46. View Neonatal enteroviral sepsis/meningoencephalitis and hemophagocytic lymphohistiocytosis: diagnostic challenges. Abstract

  36. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010 Sep 16; 116(11):1919-23. View Recurrent BRAF mutations in Langerhans cell histiocytosis. Abstract

  37. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010 Jun; 11(6):543-52. View Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Abstract

  38. Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? Dis Model Mech. 2009 Sep-Oct; 2(9-10):436-9. View Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one? Abstract

  39. Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Am J Hematol. 2008 Feb; 83(2):116-21. View Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1. Abstract

  40. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum. 2008 Feb; 58(2):567-70. View Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Abstract

  41. The Histiocytoses. Hematology of Infancy and Childhood (Orkin SH et al., eds.). 2008.

  42. Oncology (Section Editor). Comprehensive Pediatric Hospital Medicine (Zaoutis and Chiang, eds.). 2007.

  43. Childhood Cancer. Comprehensive Pediatric Hospital Medicine (Zaoutis and Chiang, eds.). 2007.

  44. Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Pediatrics. 2006 Nov; 118(5):e1593-9. View Gastrointestinal tract involvement in Langerhans cell histiocytosis: case report and literature review. Abstract

  45. Hematopoiesis following disruption of the Pitx2 homeodomain gene. Exp Hematol. 2006 Feb; 34(2):167-78. View Hematopoiesis following disruption of the Pitx2 homeodomain gene. Abstract

  46. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. Am J Hematol. 2004 Dec; 77(4):391-6. View Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. Abstract

  47. Molecular diagnostics of malignant disorders. Clin Adv Hematol Oncol. 2004 Oct; 2(10):650-60. View Molecular diagnostics of malignant disorders. Abstract

  48. Molecular Diagnostics of Malignant Disorders. Clin Advances in Hematology/Oncology. 2004; 2(10):650-660.

  49. Molecular Basis of Hematology. 2004.

  50. Molecular Basis of Hematology. 2003.

  51. Introduction to the Lymphoproliferative Disorders. Oxford Textbook of Medicine, E.J. Benz (ed). 2003.

  52. The homeodomain gene Pitx2 is expressed in primitive hematopoietic stem/progenitor cells but not in their differentiated progeny. Exp Hematol. 2001 Jul; 29(7):894-902. View The homeodomain gene Pitx2 is expressed in primitive hematopoietic stem/progenitor cells but not in their differentiated progeny. Abstract

  53. Familial Polycythemia Due to Truncations of the Erythropoietin Receptor. Transactions of the American Clinical and Climatological Association. 2000; 11:38-45.

  54. 13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma. Med Pediatr Oncol. 1999 Apr; 32(4):308-10. View 13-cis-retinoic acid-induced eosinophilia following autologous bone marrow transplantation for neuroblastoma. Abstract

  55. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood. 1997 Jun 15; 89(12):4628-35. View Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Abstract

  56. Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Blood. 1994 Nov 15; 84(10):3440-6. View Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs. Abstract

American Board of Pediatrics (General) | Education

Medical School

MBBS

Government Medical College

2010, Surat, India

Residency

Albert Einstein Medical Center

2015, Philadelphia, PA

Fellowship

Boston Children's Hospital

2018, Boston, MA

American Board of Pediatrics (General) | Publications

American Board of Pediatrics (General) | Education

Undergraduate School

Princeton University

Princeton, NJ

Graduate School

New York University

New York, NY

Medical School

Albert Einstein College of Medicine

Bronx, NY

Internship

Boston Children's Hospital

Boston, MA

Residency

Boston Children's Hospital

Boston, MA

American Board of Pediatrics (General) | Publications

American Board of Pediatrics (General) | Publications

American Board of Pediatrics (General) | Education

Medical School

University of Athens Medical School

1977, Athens, Greece

Internship

University of Athens Hospital

1979, Athens, Greece

Residency

Nassau County Medical Center, Clinical Campus SUNY at Stony Brook

1982, Stony Brook, NY

Fellowship

Tufts Medical School, New England Medical Center

1985, Boston, MA

Fellowship

Yale University School of Medicine

1988, New Haven, CT

American Board of Pediatrics (General) | Publications

American Board of Pediatrics (General) | Education

Undergraduate School

Brown University

2006, Providence, RI

Medical School

University of New England College of Osteopathic Medicine

2013, Biddeford, ME

Residency

Penn State Children's Hospital

2016, Hershey, PA

American Board of Pediatrics (General) | Education

Medical School

Yale School of Medicine

New Haven, CT

Residency

Boston Combined Residency Program (BCRP)

2015, Boston, MA

Fellowship

Pediatrics GI/Nutrition

Boston Children's Hospital

2018, Boston, MA

American Board of Pediatrics (General) | Publications

American Board of Pediatrics (General) | Education

Undergraduate School

Harvard University

1977, Cambridge, MA

Medical School

Tufts University School of Medicine

1981, Boston, MA

Internship

University of California at San Francisco

1982, San Francisco, CA

Residency

University of California at San Francisco

1984, San Francisco, CA

Fellowship

Massachusetts General Hospital

1987, Boston, MA

American Board of Pediatrics (General) | Education

Medical School

University of South Florida College of Medicine

2008, Tampa, FL

Internship

University of South Florida College of Medicine

2009, Tampa, FL

Residency

University of South Florida College of Medicine

2011, Tampa, FL

Fellowship

Pediatric Gastroenterology, Hepatology and Nutrition

Cincinnati Children’s Hospital Medical Center

2014, Cincinnati, OH

Fellowship

Advanced Clinical Nutrition

Children’s Hospital of Philadelphia

2015, Philadelphia, PA

American Board of Pediatrics (General) | Publications

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services